27 results
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
of management;
high-quality existing investors;
clean capital structure with no debt or clear path to restructuring current debt; and
for potential
S-4/A
certfiyyvlklym nvs
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
mc5dt kkv
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
cyq3ogkq
24 May 23
Business combination disclosure
7:05am
425
dbpatd
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
t9yn040v8tb3icnu fb
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
EX-1.2
csxpg3p
1 Nov 22
Shelf registration
4:51pm
10-K
5g576eb hwyq
29 Mar 22
Annual report
7:36am
10-Q
7a4e48
15 Nov 21
Quarterly report
7:54am
424B4
yzny96hurru
8 Oct 21
Prospectus supplement with pricing info
5:00pm